» Articles » PMID: 36177037

Hyperuricemia Contributes to Glucose Intolerance of Hepatic Inflammatory Macrophages and Impairs the Insulin Signaling Pathway IRS2-proteasome Degradation

Abstract

Aim: Numerous reports have demonstrated the key importance of macrophage-elicited metabolic inflammation in insulin resistance (IR). Our previous studies confirmed that hyperuricemia or high uric acid (HUA) treatment induced an IR state in several peripheral tissues to promote the development of type 2 diabetes mellitus (T2DM). However, the effect of HUA on glucose uptake and the insulin sensitivity of macrophages and its mechanism is unclear.

Methods: To assess systemic IR, we generated hyperuricemic mice by urate oxidase knockout (UOX-KO). Then, glucose/insulin tolerance, the tissue uptake of 18F-fluorodeoxyglucose, body composition, and energy balance were assessed. Glucose uptake of circulating infiltrated macrophages in the liver was evaluated by glucose transporter type 4 (GLUT-4) staining. Insulin sensitivity and the insulin signaling pathway of macrophages were demonstrated using the 2-NBDG kit, immunoblotting, and immunofluorescence assays. The immunoprecipitation assay and LC-MS analysis were used to determine insulin receptor substrate 2 (IRS2) levels and its interacting protein enrichment under HUA conditions.

Results: Compared to WT mice (10 weeks old), serum uric acid levels were higher in UOX-KO mice (WT, 182.3 ± 5.091 μM versus KO, 421.9 ± 45.47 μM). Hyperuricemic mice with metabolic disorders and systemic IR showed inflammatory macrophage recruitment and increased levels of circulating proinflammatory cytokines. HUA inhibited the nuclear translocation of GLUT-4 in hepatic macrophages, restrained insulin-induced glucose uptake and glucose tolerance, and blocked insulin IRS2/PI3K/AKT signaling. Meanwhile, HUA mediated the IRS2 protein degradation pathway and activated AMPK/mTOR in macrophages. LC-MS analysis showed that ubiquitination degradation could be involved in IRS2 and its interacting proteins to contribute to IR under HUA conditions.

Conclusion: The data suggest that HUA-induced glucose intolerance in hepatic macrophages contributed to insulin resistance and impaired the insulin signaling pathway IRS2-proteasome degradation.

Citing Articles

The link between hyperuricemia and diabetes: insights from a quantitative analysis of scientific literature.

Ma L, Wang J, Ma L, Wang X Front Endocrinol (Lausanne). 2025; 15:1441503.

PMID: 39991045 PMC: 11842261. DOI: 10.3389/fendo.2024.1441503.


Hyperuricemia-induced complications: dysfunctional macrophages serve as a potential bridge.

Gu W, Zhao J, Xu Y Front Immunol. 2025; 16:1512093.

PMID: 39935474 PMC: 11810932. DOI: 10.3389/fimmu.2025.1512093.


The Role of Beta-Hydroxybutyrate in Mitigating the Inflammatory and Metabolic Consequences of Uric Acid.

Remund N, Larsen J, Shin M, Warren C, Palmer I, Kim I Metabolites. 2024; 14(12).

PMID: 39728460 PMC: 11676148. DOI: 10.3390/metabo14120679.


Serum uric acid and nonalcoholic fatty liver disease.

Fan J, Wang D Front Endocrinol (Lausanne). 2024; 15():1455132.

PMID: 39669496 PMC: 11635646. DOI: 10.3389/fendo.2024.1455132.


Highland Barley Alleviates High-Fat Diet-Induced Obesity and Liver Injury Through the IRS2/PI3K/AKT Signaling Pathway in Rats.

Shi X, Song W, Jiang B, Ma J, Li W, Sun M Nutrients. 2024; 16(20).

PMID: 39458511 PMC: 11510035. DOI: 10.3390/nu16203518.


References
1.
Saltiel A, Olefsky J . Inflammatory mechanisms linking obesity and metabolic disease. J Clin Invest. 2017; 127(1):1-4. PMC: 5199709. DOI: 10.1172/JCI92035. View

2.
Jiang M, Kuang Z, He Y, Cao Y, Yu T, Cheng J . SNAPIN Regulates Cell Cycle Progression to Promote Pancreatic β Cell Growth. Front Endocrinol (Lausanne). 2021; 12:624309. PMC: 8237857. DOI: 10.3389/fendo.2021.624309. View

3.
Olefsky J, Glass C . Macrophages, inflammation, and insulin resistance. Annu Rev Physiol. 2010; 72:219-46. DOI: 10.1146/annurev-physiol-021909-135846. View

4.
Krenkel O, Tacke F . Liver macrophages in tissue homeostasis and disease. Nat Rev Immunol. 2017; 17(5):306-321. DOI: 10.1038/nri.2017.11. View

5.
Hotamisligil G . Inflammation and metabolic disorders. Nature. 2006; 444(7121):860-7. DOI: 10.1038/nature05485. View